Skip to main content

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

New study suggests that Novo Nordisk's Ozempic may lower dementia risk and nicotine use. Meanwhile, UnitedHealth Group's cyberattack woes aren't over yet.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.